'Votrient 400 mg' diaporamas de présentation

Votrient is a type of targeted therapy that contains multityrosine kinase inhibitor of the VEGF (vascular endothelial growth factor) receptor. Blocking the growth of tumour cells is the main function of this drug. It blocks the proteins and other targets within the cell-like tyrosine kinases which are located on the surface of tumour cells. And both proteins and target cells are the reason for a new production of blood vessels in the cancer cells and angiogenesis. And with Pazopanib working, it blocks these targets which in turn helps to destroy cancer cells. Source: https://www.cancercurepharmacy.com/BlogDetails.aspx?Title=Votrient-Treatment-for-Renal-Cell-Cancer-and-Soft-Tissue-Sarcoma

36 views • 3 slides